Mylan Laboratories (NYSE: MYL) develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.
Recent Mentions on Fool.com
- The Dow Spikes as Citigroup Settles for $7 Billion, Beats on Earnings
- What Does Generic Copaxone Mean for Teva, Mylan, and Novartis?
- Is Abbott Laboratories Headed for a Breakup?
- Monday?s Top Health Care Stories: Pfizer, AstraZeneca, Mylan, Forest, and Furiex
- Teva's Copaxone: Perspectives From a Patient and Investor